Isabella Haberbosch

Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy

The Duy Nguyen, Shabnam Shaid, Olesya Vakhrusheva et al. · Blood · 2018 · 122 citations · Full text

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Afsar Mian, Alireza Rafiei, Isabella Haberbosch et al. · Leukemia · 2014 · 64 citations

Hematological Malignancy, Tumor Biology, T315i Mutation +9

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials

Nora Liebers, Tobias Roider, Jan‐Paul Bohn et al. · Leukemia · 2019 · 27 citations

Outside Clinical Trials, Hematological Malignancy, Medicine +12

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K

Afsar Mian, Isabella Haberbosch, Hazem Khamaisie et al. · Annals of Hematology · 2021 · 13 citations · Full text